UCLA CARE Center

Offering state-of-the-art medical care and clinical trials for people living with HIV and AIDS.

About UCLA CARE Center

The UCLA Center for Clinical AIDS Research and Education (CARE) provides state-of-the-art medical care and conducts clinical trials for people living with HIV and AIDS. Our highly trained, nationally recognized physicians are leaders in the field of HIV Medicine, Infectious Diseases, Oncology and other areas relevant to the health of our patients. The CARE Center’s research team is committed to conducting a broad program of ethical and high quality clinical, behavioral and prevention research to promote the health of people living with or at risk for acquiring HIV and other infectious diseases.

Get Involved

To find out more about our CARE Center services, call 310-557-2273.

Calling for HIV Advocates!

The UCLA CARE Center Community Advisory Board (CAB) is seeking community members to join us as guests.

Flyer promoting the UCLA Health Care Cab program for patient transportation, featuring a clear call to action for recruitment and information.
People walking along a path

Help us pave the path to new HIV treatments! 

Volunteer to help find a way to make better, longer-lasting vaccines to prevent infections like COVID-19.

Tired of yearly booster shots? Be a contender.

Latest News

A masthead for a journal article titled, "Impact of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV "

Impact of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV

Host factors associated with the humoral repertoire in the COVID-negative cohort enhance our understanding of these important shifts among PWH.

A masthead for a journal article titled, "Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection "

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Symptom or viral relapse in the absence of antiviral treatment is common, but the combination of symptom and viral rebound is rare.

A masthead for a journal articled titled, "Development and Validation of a Liquid Chromatographic-Tandem Mass Spectrometric Assay for the Quantification of Cabotegravir and Rilpivirine from Dried Blood Spots"

Development and Validation of a Liquid Chromatographic-Tandem Mass Spectrometric Assay for the Quantification of Cabotegravir and Rilpivirine from Dried Blood Spots

The authors developed and validated a novel LC-MS/MS assay for the quantification of CAB and RPV from DBS, and identified conversion factors to estimate plasma concentrations from spotted blood.

Get in Touch

To find out more about our CARE Center services, call 310-557-2273.